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ABSTRACT 
 
Doublecortin (DCX) is expressed in young neurons and functions as a microtubule-
associated protein. DCX is essential for neuronal migration because humans with 
mutations in the DCX gene exhibit cortical lamination defects known as lissencephaly in 
males and subcortical laminar heterotopia (or double cortex syndrome) in females. 
Phosphorylation of DCX alters its affinity for tubulin and may modulate neurite 
extension and neuronal migration.  
Previous in vitro phosphorylation experiments revealed that cyclin-dependent kinase 
5 (Cdk5) phosphorylates multiple sites of DCX, including Ser332 (S332); however, 
phosphorylation at only Ser297 has been shown in vivo.  
In the present study, I examined phosphorylation of S332 of DCX in the Cdk5-/- 
mouse brain and results found, unexpectedly, indicate an increased DCX 
phosphorylation at S332. I found that JNK, not Cdk5, phosphorylates DCX at S332 in 
vivo. To examine the physiological significance of S332 phosphorylation of DCX in 
neuronal cells, I transfected cells with either GFP, GFP-DCX-WT, or GFP-DCX-S332A 
and analyzed neurite extension and migration. Introduction of GFP-DCX-WT enhanced 
neurite extension and migration. These effects of DCX introduction were suppressed 
when I used GFP-DCX-S332A. When neurons were treated with a JNK inhibitor, the 
amount of DCX that bound to tubulin was increased. Interestingly, amount of DCX that 
bound to tubulin decreased in Cdk5-/- brain homogenates, which indicates that 
phosphorylation of DCX by JNK is critical for the regulation of DCX binding to tubulin. 
These results suggest the physiological importance of phosphorylation of DCX for its 
function. 
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CHAPTER 1.  
INTRODUCTION 
 
1.1 Neuronal migration 
     Mammalian cerebral cortex development is characterized by regulated migration of 
each post-mitotic neuron over hundreds of cell body distance from their sites of origin. 
There are two modes of neuronal migration. The cerebral cortex consists of six layers, 
with uniform positioning of neurons of specific function (Tanaka et al., 2004).  
 
 
 
Figure 1.1 Neuronal migration in mouse brain. 
A. Coronal section of mouse brain. B. Cerebral cortex in developing mouse brain consists of 
six layers. Cells migrate to the superficial layer by changing their form multipolar stage to 
bipolar stage. PP: Preplate, MZ: Marginal Zone, CP: Cortical plate, IZ: Intermediate zone, VZ: 
Ventricular zone.  
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In the radial migration, six-layer structure of the cerebral cortex is generated in an 
inside-out manner, wherein the neurons that were generated first reach the deepest layer, 
while the subsequently generated neurons migrate to the superficial layers of the cortical 
plate (Angevine and Sidman, 1961; Fig.1.1). Tangential migration is defined as a mode 
of non-radial neuronal translocation that does not require specific interactions with 
radial glial cell processes. In the tangential migration, cells migrate orthogonally to the 
direction of radial migration. Failure of the neuronal migration of the cells to 
appropriate location can result in brain development disorders (Kriegstein et al., 2004; 
Marin et al., 2001; Marin et al., 2003). Impairment of neuronal migration in cerebral 
cortex causes lissencephaly in human patients (Bai et al., 2003).  
 
1.2 Doublecortin  
Male patients with X-linked lissencephaly have neuronal migration defects with 
severe seizure disorders as well as mental retardation (Berg et al., 1998). These people 
have a thickened disorganized cortex, lacking the characteristic laminar pattern, and the 
surface of the brain is smooth without the gyri of folds found in normal brain (Francis et 
al, 1999). Causative mutations have been identified in the doublecortin (DCX) gene in 
X-linked lissencephaly patients (Gleeson et al., 1998; des Portes et al., 1998).  Female 
patients with DCX gene mutations exhibit subcortical laminar heterotopia (or double 
cortex syndrome). 
DCX is expressed in young and migrating neurons and functions as a microtubule-
associated protein (MAP). DCX mRNA is found in high expressions in embryonic 
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brain and restricted areas in postnatal brain (Fig. 1.2). DCX protein is abundant in the 
cell soma as well as tips of neurites (Gleeson et al., 1999).  
A previous study has revealed that RNAi of DCX has been shown to cause 
migrating neurons to adopt multipolar morphologies (Bai J et al., 2003).   
DCX consists of two tubulin-binding domains and a C-terminal serine (Ser)/proline 
(Pro)-rich domain (Gleeson et al., 1999), which contains multiple phosphorylation sites 
for Pro-directed Ser/Thr kinases such as c-Jun N-terminal kinase (JNK) and Cyclin-
dependent kinase 5 (Cdk5) (Fig. 1.3). Mutations in DCX gene in lissencephaly patients 
were mostly identified within tubulin-binding domains, suggesting function of DCX as 
a MAP. 
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Figure 1.2 DCX expression at P12 in mouse brain. 
A-G. Sagittal sections of mouse brain at P12 were hybrized with DCX probe. DCX was 
observed in olfactory bulb (B), hippocampus (C), cerebral cortex (D), rostral migratory stream 
(E), and cerebellum (F, G). Scale bar, 500 μm. 
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Figure 1.3 Schematic structure of DCX and comparison of amino acid sequence of human 
with that of mouse with putative phosphorylation sites.  
DCX consists of two tubulin-binding domains (R1 and R2) and the C-terminal Ser/Pro(S/P)-rich 
domain, including phosphorylation sites of JNK and Cdk5. Because human DCX lacks 5 amino 
acids that are indicated by dashes, numbering of amino acids differ. Mouse Ser332 is equivalent 
to human DCX Ser327. *, phosphorylation sites of JNK were determined in a previous study 
(Gdalyahu et al., 2004). In vitro Cdk5 phosphorylation sites, including Ser332 (underlined), 
(Graham et al., 2004) are indicated in italics. **, Ser297 is phosphorylated by Cdk5 in vitro and 
in vivo (Tanaka et al. 2004). 
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1.3 Cyclin-dependent kinase 5 
Cyclin-dependent kinase 5 (Cdk5), a proline-directed serine (Ser)/threonine (Thr) 
kinase, had been identified as a member of the CDK family. Cdk5 is regulated by 
binding with one of its neuron-specific regulatory subunits, either p35 or its isoform p39 
(Tsai et al., 1994; Tang et al., 1995).  
Cdk5 expression is basically ubiquitous and, unlike other Cdks, its kinase activity is 
abundant in neuronal cells (Tsai et al., 1993). Cdk5-/- mice have shown that perinatal 
death with the disruption of the laminar structures in the cerebral cortex, olfactory bulb, 
hippocampus, and cerebellum (Ohshima et al., 1996; Ko et al., 2001) (Fig. 1.4). p35-/- 
mice display a milder phenotype than Cdk5-/- mice because of the redundancy of p39 
(Ohshima et al., 2001). p39-/- mice display no phenotype, but p35/p39 double knockout 
mice display a phenotype identical to that of Cdk5-/- mice (Ko et al., 2001).  
Cdk5 phosphorylates a wide range of protein substrates, such as MAP1b, Tau, DCX, 
PAK1, and so on. Previous studies have revealed that Cdk5 phosphorylation modulates 
neurite extension and neuronal migration by regulating the binding of microtubules 
(Paglini et al., 1998; Pigino et al., 1997; Patrick et al., 1999; Nikolic et al., 1998; Rashid 
et al., 2001; Tanaka et al., 2004). Tanaka et al. reported that DCX at Ser297 is 
phosphorylated by Cdk5 in vivo. Phosphorylation of DCX by Cdk5 at Ser297 decreases 
its ability to bind and stabilizes microtubules, and this phosphorylation is necessary for 
DCX-induced migration (Tanaka et al., 2004). Cdk5-/- mice exhibit elevated c-Jun N-
terminal kinase and GSK3 activity (Li et al., 2002; Morfini et al., 2004).  
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Figure 1.4 Inverted layering of the cerebral cortex in Cdk5-/- mice at E18.5.  
Coronal sections of Cdk5 -/- mouse brain at E18.5 show disruption of the laminar structures in 
the cerebral cortex. While radial migration of cortical neuron in Cdk5 -/- mice was greatly 
disturbed, cortical plate (CP) is easily visible in Cdk5 +/-. Scale bar in upper panels, 500 μm, 
and scale bar in lower panels, 200 μm.  
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1.4 c-Jun N-terminal kinase 
The c-Jun N-terminal kinases (JNKs) are members of the mitogen-activated protein 
kinase (MAPK) family and regulate apoptosis, planar cell polarity, cell migration, 
transformation, embryonic morphogenesis, and differentiation (Davis, 2000).  
The mammalian JNKs are encoded by three distinct genes; Jnk1, Jnk2, and Jnk3. 
While JNK1 and JNK2 are expressed in a variety of tissues, JNK3 is especially 
expressed in the brain, heart, and testis (Gupta et al., 1996). Introduction of a dominant-
negative form of JNK has been shown to impair neuronal migration in the embryonic 
cerebral cortex (Kawauchi et al., 2003).  
        Dual leucine zipper kinase (DLK) is a member of the mixed-lineage kinases and 
functions as an MAPKKK in the JNK pathway (Gallo and Johnson, 2002). Expression 
of DLK protein is highly specific to neural tissues in mouse embryos (Hirai et al., 2005). 
DLK expression in the developing cerebrum is restricted to cell layers in which JNK 
activity is potently induced (Hirai et al., 2002). DLK-/- mice exhibit decreased JNK 
activity and neuronal migration defects in cerebral cortex (Hirai et al., 2006). Axon 
growth of neocortical pyramidal neurons was also significantly impaired in DLK-/- 
mice.  
 Three JNK phosphorylation sites on DCX have been identified (Gdalyahu et al., 
2004; Thr321, Thr331, and Ser334 in human DCX and those residues correspond to 
Thr326, Thr336, and Ser339 in mouse DCX, as shown in Fig. 1.3), and phosphorylation 
levels at these sites were decreased in the brain of DLK-/- mice (Hirai et al., 2006).  
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1.5 Purpose of the study 
     A previous in vitro study has shown that Cdk5 phosphorylates multiple sites within 
the C-terminus of DCX including Ser332 of mouse DCX (Graham et al., 2004). 
Gdalyahu et al. reported that JNK phosphorylates DCX at Thr321, Thr331, and Ser334 
in human DCX and corresponding to Thr326, Thr336, and Ser339 in mouse DCX 
(Gdalyahu et al., 2004). They demonstrated these phosphorylations related to neurite 
extension and neuronal migration. However, they did not examine DCX 
phosphorylation at Ser332.  
    To investigate DCX phosphorylation at Ser332, I generated phosphospecific 
antibody against Ser332 of DCX. If Cdk5 phosphorylates DCX at Ser332, the 
phosphorylation levels were expected to decrease in Cdk5-/- mice. 
I first analyzed phosphorylation level of Ser332 in Cdk5-/- mouse brain to exam 
whether Ser332 of DCX is Cdk5 phosphorylation site in vivo.  
Preliminary a study had indicated that the Cdk5-/- mouse brain revealed elevated 
phosphorylation levels at Ser332 of DCX. Therefore I tried to identify the kinases 
which phosphorylate DCX at Ser332.  
Finally, I tried to find the functional significance of phosphorylation of DCX at 
Ser332 in neurite extension and neuronal migration.  
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1.6 Materials and Methods 
1.6.1 Mice 
The mice used in the experiments were housed in accordance with protocols 
approved by the Institutional Animal Care and Use Committee at Waseda University, 
RIKEN Brain Science Institute, and Yokohama City University, School of Medicine. 
Embryos from pregnant female mice on embryonic day (E) 14.5, E16.5, and postnatal 
day (P) 12 were obtained from a colony of ICR mice (Japan SLC, Shizuoka, Japan). 
Cdk5-mutant mice (Ohshima et al., 1996) and DLK-mutant mice (Hirai et al., 2006) 
were genotyped as described (Ohshima et al., 2002; Hirai et al., 2002). Both mutant 
mice were bred with C57BL/6 mice for six generations and maintained in a C57BL/6 
background.  
 
1.6.2 Cell culture  
Primary dissociated cortical neurons from ICR E14.5 embryos were cultured as 
previously described (Ohshima et al., 2007). Briefly, the cerebral cortex was excised, 
incubated with 0.25% trypsin in PBS for 5 minutes at 37°C, dissociated, and washed in 
culture medium which consisted of B27 supplement (Invitrogen, U.S.A), and penicillin 
and streptomycin. SH-SY5Y, 293T, and COS cells were cultured in DMEM media 
containing 10% FBS. For inhibitor experiments, cortical neurons were incubated with 
either 20 µM roscovitine, 10 µM anisomycin, 5 mM LiCl, 20 µM JNK inhibitor 
SP600125, 20 µM SB216763, or DMSO for 4 hour (h), and cell lysates were recovered 
and subjected to western blot analysis, or cells were fixed with 4% paraformaldehyde 
for 15 min at room temperature and subjected to immunocytochemical staining. In some 
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experiments, SH-SY5Y and COS cells were treated with 20 µM of the JNK inhibitor 
SP600125 for 4 h.  
 
1.6.3 Plasmid construction and transfection 
By using a previously described method (Tsukada et al., 2005), I generated GFP-
DCX-WT by subcloning the mouse DCX coding region, which was amplified by PCR 
with Pyrobest polymerase (Takara Biotechnology, Japan), into the pEGFP-C1 vector 
(Clontech, U.S.A). Ser332 of DCX-WT was replaced with Ala (S332A) by site-directed 
mutagenesis using PCR and subcloned into pEGFP-C1 to generate GFP-DCX-S332A. 
Plasmid DNA was introduced into cultured cells by using Lipofectamine 2000 
(Invitrogen, U.S.A) according to the manufacturer’s protocol.  
 
1.6.4 Generation of anti-phospho-S332 DCX (pDCXS332) antibody and of 
the primary antibodies 
Rabbits were immunized with a DCX synthetic phosphopeptide comprising amino 
acids 322 to 342: SQLSTOKSKQpSPISTPTSPGS (where pS is phosphoserine at 332). 
Numbering of amino acids corresponds to that of mouse DCX. Mouse DCX Ser332 is 
equivalent to human DCX Ser327 (Fig. 1.3). The antiserum was affinity-purified by 
sequentially passing through nonphosphopeptide and phosphopeptide columns. First, 
flow-through with nonphosphopeptide column was applied to phosphopeptide column.  
Then, binding protein was eluted and concentrated fractions were collected. The 
specificity of purified antibody was tested using western blot analysis and 
immunocytochemical staining of COS cells transfected with either GFP-DCX-WT or 
GFP-DCX-S332A. Anti-doublecortin antibody was purchased from BD Bioscience 
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Pharmingen. Polyclonal antibody to active JNK (pJNK) and monoclonal antibody to 
neuron-specific β-III-tubulin were obtained from Promega and Covance, respectively. 
Polyclonal anti-β-tubulin and anti-GFP antibodies were obtained from Sigma and MLB, 
respectively.  
 
1.6.5 Nissl stain  
       Sections were stained with 0.05% toludine blue for 5min, and dehydrated with 
ethanol and lemosol. Then, sections were mounted in Permount (Fisher Scientific, 
U.S.A). 
 
1.6.6 In situ hybridization  
In situ hybridization was performed using 14-µm sagittal sections of ICR mouse 
brain at P12. Sections were permeated with 1 µg/ml proteinase K at 37°C for 7 min, 
prehybridized at 58°C for 1 h. DIG-labeled DCX anti-sense probe was generated by in 
vitro transcription of linearized pBluescript SK- plasmid containing mouse DCX 
cDNA insert using T7 RNA polymerase. Sections were incubated with the DCX probe 
in hybridization solution at 58°C overnight (DCX probe concentration was 100 ng/ml). 
Hybridization solution contained 5X SSC, 2% Blocking reagent, 50% formamide, 0.1% 
SDS, and 0.1% N-Lauroylsarcosine. Sections were immersed twice with 2X SSC and 
50% formamide for 1hr at 58°C and immuno-labeled with 1:2000 anti-DIG antibody-
AP for 1hr at room temperature. After reaction, sections were developed with 
NBT/BCIP (Roche, Germany) and mounted in Permount (Fisher Scientific, U.S.A).  
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1.6.7 Immunostaining and imaging analysis 
The embryos were perfusion-fixed with 4% paraformaldehyde in PBS, and the 
brains were removed from the skull and immersed in the same fixative overnight at 4°C. 
The brains were equilibrated in 20% sucrose in PBS at 4°C and embedded in OCT 
compound. Coronal sections of embryonic mouse brains were cut (14-µm thick) using a 
frozen microtome. Immunostaining of the sections was performed as previously 
described (Ohshima et al., 2007). In brief, after blocking nonspecific binding of 
antibodies, the sections were incubated with indicated primary antibodies diluted in 
PBS/0.01% Triton X-100 at 4°C overnight, followed by incubation with Alexa-
Fluor488 (1:1000) or Alexa-Fluor568 (1:1000) secondary antibodies for 1 h. 
Immunostaining of the cultured cells or neurons was performed as previously described 
(Ohshima et al., 2007). The nucleus was stained with DAPI (Roche, Germany). After 
embedding the sections in Vectorshield media (Vector), the images acquired were 
analyzed using Olympus BX51 and a large scanning confocal microscope equipped 
with the Fluoview FV1000 scanning unit (Olympus, Tokyo, Japan). The captured 
images were analyzed using Image J, and neurites were defined as protrusions longer 
than cell-body length. Neurite length of more than 35 cells (or 100 neurons) from 3 
independent experiments was averaged. Statistical analysis was conducted using 
Student’s t test, and average +/- S.E.M. is shown in the graph. 
 
1.6.8 Western blot analysis and immunoprecipitation 
Western blot analysis was conducted as previously described (Ohshima et al., 2007). 
In brief, brain samples were homogenized with TNN buffer (50 mM Tris, pH 8.0, 150 
mM NaCl, 1% NP-40) containing 0.2 mM Na3VO4, 50 mM NaF, complete protease 
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inhibitor cocktail (Roche Applied Science, Berkeley, CA), phosphatase inhibitor 
cocktail (Roche Applied Science, Germany), 5 µM okadaic acid, and 0.5 µM 
microcystin LR. The protein concentration in each sample was determined using the 
BSA protein assay. Equal amounts of protein were separated using SDS-PAGE. The 
membranes were blocked in 3% skim milk in TBS buffer containing 0.01% Tween 20 
(TBST) and then incubated with primary antibodies at 4°C overnight. After the 
membranes were washed with TBST, they were incubated with secondary antibodies 
conjugated to HRP. After reaction with the ECL reagent, a signal was detected by LAS-
3000 (Fujifilm, Japan). For immunoprecipitation, 2 µl of anti-β-tubulin antibody was 
added to 500 µg of pre-cleared lysates of cultured cortical neurons or embryonic brains 
and incubated for 1 h at 4°C. Further, 25 µl of Protein G (Pierce) was added, and after 
incubation for 1 h at 4°C, the immune complex was centrifuged at 7,000 rpm for 1 min 
at 4°C, and the pellet was washed three times with TNN buffer containing a protease 
inhibitor cocktail. Subsequently, 10 µl of 5x SDS sample buffer was added to the pellet, 
and the samples were boiled and subjected to western blot analysis with anti-DCX 
antibody. The same membrane was re-blotted with anti-β-tubulin antibody. Data were 
obtained from 3 independent experiments. Statistical analysis was conducted using 
Student’s t test, and average +/- S.E.M. is shown in the graph. 
 
1.6.9 In vitro kinase assay  
GST-DCX-WT and GST-DCX-S332A were purified as previously described 
(Uchida et al., 2005). The in vitro kinase assay was performed as follows: 5 µg of GST-
DCX-WT or GST-DCX-S332A was mixed with or without 2 µl of purified active JNK1 
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(Upstate). The kinase reaction was initiated by addition of 2x reaction buffer (100 mM 
HEPES, pH 7.2, 20 mM MgCl2, 2 mM DTT, 0.2 mM ATP). After incubation for 30 min 
at 30 °C, the resultant reaction mixtures were subjected to western blot analysis as 
described above. Another duplicate set of SDS-PAGE gels was stained with Coomassie 
Brilliant Blue (CBB) by standard methods. 
 
1.6.10 Scrape migration assay 
Scrape migration assays were used as a model assay for neuronal migration and 
performed as previously described (Huang et al., 2009). SH-SY5Y cells were 
transfected with indicated plasmids for 24 h; thereafter, the cells were scraped (width, 
100 µm), and the percentage of GFP-positive cells (more than 40 cells from 3 
independent experiments) in the scraped area was counted after 24 or 48 h.  
 
 
 
 
Figure 1.5 Schematic drawing of the scrape migration assay. 
The percentage of GFP-positive SH-SY5Y cells within the scraped area was analyzed 24 or 48 
h after the scraping. 
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CHAPTER 2.  
RESULT-1: JNK phosphorylates DCX at Ser332  
 
2.1 Production and characterization of pDCXS332 antibody 
DCX is a microtubule-associated protein and its carboxyl-terminal (C-terminal) is 
phosphorylated by several kinases.  
A previous study showed that JNK phosphorylates DCX at three sites (Fig. 1.3) in 
vitro and in mouse brain (Gdalyahu et al., 2004). Graham et al. reported that Cdk5 
phosphorylates multiple sites within the DCX C-terminal region in vitro, including 
Ser332 (S332). However, among them, only Ser297 was reported to be phosphorylated 
in the mouse brain (Tanaka et al., 2004).  
Phosphospecific antibody against S332 of DCX was generated as described in 
Section 1.5.4, and named anti-pDCXS332 antibody. To identify whether anti-
pDCXS332 antibody properly reacts, I introduced GFP-DCX-WT, or GFP-DCX-S332A 
into COS cells in which endogenous DCX does not present. After two days, transfected 
cells were fixed and subjected to immunocytochemistry. Cells expressing GFP-DCX-
WT were stained with anti-pDCXS332 antibody, but this effect was not observed in the 
cells expressing GFP-DCX-S332A (Fig.2.1). This result suggests that GFP-DCX is 
phosphorylated at S332 in COS cells, and pDCXS332 antibody reacts specifically with 
phosphorylated DCX at Ser332. 
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Figure 2.1 Immunocytochemical staining of COS cells expressing either GFP-DCX-WT or 
GFP-DCX-S332A with anti-pDCXS332 antibody. 
Anti-pDCXS332 antibody stained cells expressing GFP-DCX-WT but not those expressing 
GFP-DCX-S332A, indicating the specificity of this antibody. Scale bars, 20 μm. 
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2.2 Expression of pDCXS332 in neuronal cells and mouse brain 
To study the phosphorylation state of DCX at S332 in developing mouse brain, I 
conducted immunohistochemistry using mouse embryonic brain at E14.5 and E16.5. 
Brain sections were stained with anti-DCX, anti-pDCXS332 as well as anti-pJNK 
antibodies.  
In mouse brain, high-level immunoreactivity of pDCXS332 was observed in the 
intermediate zone (IZ) of the cerebral cortex at E14.5 and E16.5 (Fig. 2.2A). I also 
stained postnatal cerebellum at P12 (Fig. 2.2B) because in situ hybridization 
experiments indicated a high level expression of DCX in developing cerebellum 
(Fig.1.2).  
   Cerebellar granule cell progenitors are produced in the rhombic lip, after that, 
migrate over the cerebellar primordium to form a secondary proliferative zone, the 
external granule cell layer (EGL). During early postnatal development, committed 
granule cell precursors in the outer zone of the EGL proliferate, then exit the cell cycle, 
differentiate and migrate through the molecular layer (ML) past the Purkinje cells to 
their destination, the internal granule cell layer (IGL) (Borghesani et al., 2001). 
In the postnatal developing cerebellum, pDCXS332 was stained in granule cells, 
which resided in the premigratory or migrating state (Fig. 2.2B). I also found that 
pDCXS332 and pJNK were colocalized in the cerebral cortex and cerebellum.  
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Figure 2.2 Phosphorylation state of DCX at Ser332 in developing mouse brain. 
A, B. Coronal sections of mouse brain at E14.5 (A a–e) and E16.5 (A f–j) and sagittal sections 
of P12 mouse brain (B a–e) were immunostained with anti-DCX antibody, anti-pDCXS332 
antibody, active JNK (pJNK) antibody, and DAPI (blue). Higher immunoreactivities of 
pDCXS332 and pJNK were found in the intermediate zone (IZ) of cerebral cortex and 
premigratory zone of cerebellar cortex (arrows in b’, c’, d’ and e’). Images A a’–j’ and B a’–e’ 
are higher magnifications of A a–j and B a–e, respectively. Scale bars in A, 500 μm, and scale 
bars in B, 250 μm. CP (cortical plate) and IZ are indicated in the cerebral cortex. External 
granule cell layer (EGL) in B indicates its position in the cerebellar cortex.  
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To investigate expression of DCX and phosphorylation state of S332, cortical 
neurons were stained with anti-DCX, anti-pDCXS332, and Tuj1 antibodies. Tuj1 reacts 
with neuron-specific βIII-tubulin. pDCXS332 was detected in neuronal soma and 
neurites of cultured primary cortical neurons (Fig. 2.3). 
 
 
 
Figure 2.3 Phosphorylation state of DCX at Ser332 in cultured cortical neurons.  
Phosphorylation of DCX at Ser332 in cortical neurons. The cultured primary cortical neurons at 
DIV2 were immunostained with anti-DCX antibody, anti-pDCXS332 antibody, anti-Tuj1 
antibody, and DAPI (blue). Scale bar, 100 μm. 
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pDCXS332 was found at high levels in the cultured neurons at DIV2 to DIV4. 
These results indicated that phosphorylation of DCX at S332 is related to neurite 
extension. To examine phosphorylation levels at Ser332 of DCX and JNK, cortical 
neurons were analyzed by western blot. The phosphorylated DCX at S332, DCX, JNK, 
and pJNK in cortical neurons were detected at high levels within time course (Fig. 2.4).  
Taken together, these results indicate that DCX is phosphorylated at S332 in 
developing mouse brain and cultured cortical neuron.  
 
 
 
 
 
 
Figure 2.4 In vitro expression of DCX, pDCXS332, JNK, and pJNK in cortical neurons. 
A, B. Western blot analysis of mouse cortical neurons revealed presence of DCX, pDCXS332, 
JNK, and pJNK in all culture days.     
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2.3 Elevated phosphorylation level of pDCXS332 in Cdk5 KO mice 
To determine whether S332 of DCX is phosphorylated by Cdk5 in vivo, I examined 
the phosphorylation level of DCX in the embryonic brain from Cdk5-/- mice. In the 
wild-type (Cdk5+/-) mouse brain at E18.5, immunoreactivity of pDCXS332 remained 
high at the IZ of the cerebral cortex. Unexpectedly, strong positive staining of anti-
pDCXS332 was detected throughout the wall of the cerebral cortex, except in the 
ventricular zone (VZ), in Cdk5-/- embryos (Fig. 2.5A).  
In western blot analysis, the phosphorylation level of DCX at S332 
(pDCXS332/DCX) in the Cdk5-/- brain was elevated by 2.7-fold as compared to levels 
in Cdk5+/- mice (Fig. 2.5B). This study also revealed slight elevation of DCX protein 
expression in Cdk5-/- mice (Fig. 2.5B). 
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Figure 2.5 Elevated phosphorylation levels of DCX at Ser332 in Cdk5-/- mouse embryo at 
E18.5.  
A. Immunostaining of the coronal sections of the cerebral cortex of Cdk5+/- (a–e) and Cdk5-/- 
(f–j) mice at E18.5 with anti-DCX antibody (a, f), anti-pDCXS332 antibody (b, g), active JNK 
(pJNK d, i), and DAPI (blue). a’–j’ are higher magnifications of the cerebral cortex shown in a–
j. CP and IZ are indicated in the cerebral cortex. Higher levels of pDCXS332 staining were 
observed throughout the cerebral cortex of the Cdk5-/- mouse brain. Scale bars, 500 μm. B. 
Western blot analysis of E18.5 brain homogenates revealed elevated phosphorylation levels of 
DCX at Ser332 in Cdk5-/- embryos. Slight elevation of the total amount of DCX was also 
observed in the Cdk5-/- embryonic brain. n=4, *, p < 0.05, ***, p < 0.001.  
 35 
2.4 JNK, not Cdk 5, phosphorylates DCX at Ser332 
To identify whether Cdk5 phosphorylates DCX at S332, cortical neurons were 
treated with Cdk inhibitor roscovitine. When cortical neurons were incubated for 4h 
with the Cdk inhibitor roscovitine at DIV4, the level of pDCXS332 was not altered (Fig. 
2.6A). This result suggests that kinase(s) other than Cdk5 phosphorylate DCX at S332 
in vivo. 
Previous studies have reported that the kinase activities of GSK3β and JNK are 
elevated in the brain of Cdk5-/- mice and neurons treated with a Cdk inhibitor (Li et al., 
2002; Morfini et al., 2004). To investigate the involvement of GSK3β and JNK in the 
phosphorylation of DCX at S332, I treated cultured cortical neurons with inhibitors of 
these kinases and quantified pDCXS332 by Western blot analysis. 
In these experiments, I observed that treatment with a JNK inhibitor significantly 
decreased band intensities of pDCXS332 without altering those of DCX, demonstrating 
the suppressed phosphorylation levels of DCX at S332 (8.0% of control, p < 0.05, Fig. 
2.6B, C). In the treatment with SB216763, a specific inhibitor of GSK3β, the level of 
pDCXS332 remained unaltered. When I treated cultured neurons with anisomycin, an 
activator of JNK, elevation of pDCXS332 levels (189.0%) was observed although the 
difference was not significant (p = 0.052, Fig. 2.6B, C).  
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Figure 2.6 JNK, not Cdk5, phosphorylates DCX at Ser332 (DCXS332).  
A. Treatment with a Cdk inhibitor, roscovitine, did not alter phosphorylation levels of 
DCXS322 in cultured cortical neurons. Neurons were incubated with 20 µM roscovitine for 4 h. 
B, C. JNK inhibitor but not GSK inhibitors (LiCl and SB216763) suppressed phosphorylation 
levels of DCXS322 in cultured cortical neurons. Treatment with the JNK inhibitor significantly 
suppressed phosphorylation, and anisomycin treatment increased phosphorylation levels of 
DCXS322 in cultured cortical neurons. n=4, *, p < 0.05.  
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I then conducted an immunocytochemical study of cultured neurons treated with a 
JNK inhibitor. Suppression of pDCXS332 in the presence of a JNK inhibitor was also 
observed by immunostaining of cultured neurons (Fig. 2.7). In addition, staining 
patterns of pDCXS332 of the mouse brain indicate the correlation with those of active 
JNK (pJNK) (Fig. 2.2 and Fig. 2.5A). These results indicate that JNK phosphorylates 
DCX at S332 in cultured neurons as well as in mouse brain.  
 
 
 
Figure 2.7 Suppression of phosphorylation of DCX at S332 by JNK inhibitor 
DCX is phosphorylated at S332 by JNK in cortical neurons. The cultured primary cortical 
neurons at DIV4 were incubated with or without the JNK inhibitor for 4 h. Fixed neurons were 
immunostained with anti-DCX, anti-pDCXS332, and anti-Tuj1 antibodies as well as DAPI 
(blue). Note that immunoreactivities of pDCXS332 were almost eliminated in the neurons 
treated with the JNK inhibitor. Scale bars, 100 μm.  
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However, JNK may activate other kinase(s) and contribute to the phosphorylation of 
DCXS332. To confirm the direct phosphorylation of DCX at S332 by JNK, I conducted 
an in vitro kinase assay using GST-DCX-WT and GST-DCX-S332A proteins followed 
by a western blot analysis. DCX-S332A is a phosphorylation defect mutant in which the 
Ser residue is replaced with Ala at 332 of DCX. I used purified JNK1 as an active 
kinase.  
In the anti-pDCXS332 antibody assay, phosphorylation of DCX at S332 was 
detected during reactions with GST-DCX-WT but not with GST-DCX-S332A, and this 
finding confirmed the direct phosphorylation of DCX at S332 by JNK in vitro (Fig. 2.8).  
 
 
 
 
 
Figure 2.8 JNK directly phosphorylates DCX at Ser332 in vitro 
In vitro kinase assay revealed that JNK phosphorylates DCX at S332 in vitro. GST-fusion 
protein of full-length DCX and DCX-S332A were incubated with or without active JNK in vitro 
at 30 °C. After 30 min, the reaction mixture was subjected to western blot analysis. The 
pDCXS332 antibody was used to detect direct phosphorylation of DCX by JNK in vitro.  
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DLK activates JNK (Gallo and Johnson, 2002), and decreased phosphorylation 
levels of other JNK-phosphorylation sites of DCX have been reported in the brain of 
DLK-/- mice (Hirai et al., 2006). I analyzed pDCXS332 levels in brain homogenates 
from DLK-/- and DLK+/+ embryos at E16.5. The level of pDCXS332 was slightly but 
significantly decreased (89.9% of control) in DLK-/- brain homogenates (Fig. 2.9), as 
compared to DLK+/+ homogenates. Taken together, these results indicate that JNK 
phosphorylates DCX at S332 in vitro and in vivo. 
 
 
 
 
Figure 2.9 Phosphorylation of DCX at S332 in DLK-/- mice 
Phosphorylation levels of DCXS332 were decreased in the DLK-/- embryonic brain. n=4, *, p < 
0.05. 
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CHAPTER 3.   
RESULT-2: Phosphorylation of DCX Ser332 modulates DCX-
dependent neurite extension 
 
3.1 Phosphorylation of DCX Ser332 modulates DCX-dependent 
neurite extension of SH-SY5Y cells 
Previous studies have reported that phosphorylation of DCX by JNK at other three 
sites, which correspond to Thr326, Thr336, and Ser339 in mouse DCX (Fig. 1.3), 
affected neurite outgrowth and neuronal migration (Gdalyahu et al., 2004).  
Waetzig and Herdegen reported that JNK is involved in the NGF-dependent neurite 
extension in PC12 cells (Waetzig and Herdegen., 2003). To identify whether the 
phosphorylation of DCX at S332 by JNK regulates NGF-dependent neurite extension in 
PC12 cells, cells were transfected with GFP-DCX-WT. Two days after transfection, 
NGF (50 ng/ml) was added to the PC12 cells. And after two days, cells were fixed. In 
immunostaining analysis, phosphorylation of DCX Ser332 was detected in NGF-
induced extended neurites (Fig. 3.1). These results suggest possible involvement of 
S332 phosphorylation of DCX in the neurite extension via NGF-JNK signaling in PC12 
cells. 
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Figure 3.1 Phosphorylation of DCX at Ser 332 in NGF-dependent neurite extension of 
PC12 cells.  
PC12 cells were transfected with GFP-DCX-WT, and cells were treated with NGF or BSA 48 h 
after transfection. Arrows indicate that DCX is strongly expressed in the tips of neuritis. Scale 
bar, 100 μm. 
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To investigate the role of phosphorylation of DCX at S332, I introduced GFP, GFP-
DCX-WT, or GFP-DCX-S332A into SH-SY5Y neuroblastoma cells. As shown in 
Figure 3.2A, SH-SY5Y cells expressing GFP-DCX-WT increased the incidence and 
length of neurites extending from the cell body compared to those expressing GFP alone. 
GFP-DCX-S332A expression in SH-SY5Y cells did not alter either the incidence or 
length of neurite outgrowth. This result indicates that phosphorylation of DCX at S332 
is required for DCX-mediated neurite outgrowth.  
To test whether treatment with a JNK inhibitor suppressed the effects of DCX on 
neurite extension, SH-SY5Y cells, which were transfected with GFP or GFP-DCX-WT, 
were exposed to the JNK inhibitor for 4 h. Cells transfected with GFP-DCX-WT had 
significantly extended neurites, the lengths of neurites were decreased with JNK 
inhibitor treatment (Fig. 3.2B). 
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Figure 3.2 Phosphorylation of DCX at S332 modulates DCX-dependent neurite extension 
in neuroblastoma SH-SY5Y cells.  
A. SH-SY5Y cells were transfected with GFP, GFP-DCX-WT, or GFP-DCX-S332A, and cells 
were analyzed 48 h after transfection. Arrows indicate extended neurites. Scale bars, 50 μm. B. 
Effect of JNK inhibitor treatment on cells transfected with GFP or GFP-DCX-WT. Arrows 
indicate extended neurites. Scale bars, 50 μm. * p < 0.05, ** p < 0.01, *** p < 0.001. 
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3.2 Phosphorylation of DCX Ser332 modulates DCX-dependent 
neurite extension of mouse cortical neuron 
I next examined whether DCX phosphorylation leads to neurite extension in 
primary cultured neurons. Cortical neurons at DIV2 were transfected with GFP, GFP-
DCX-WT, or GFP-DCX-S332A, and their neurite extension was analyzed at DIV4. As 
shown in Figure 3.3, a slight increase in the length of the neurites in neurons expressing 
GFP-DCX-WT as well as GFP-DCX-S332A was observed.  
Neurons expressing GFP-DCX-WT had more extended neurites (average, 204.6 
µm; longest, 389.1 µm) than did those expressing GFP (average, 52.4 µm; longest, 82.0 
µm). Expression of GFP-DCX-S332A suppressed neurite extension (average, 107.2 µm; 
longest, 178.5 µm) compared with the GFP-DCX-WT expression. These results are 
consistent with the neurite extension data in SH-SY5Y cells, and taken together, these 
results indicate that phosphorylation of DCX at S332 is required for DCX-induced 
neurite extension. 
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Figure 3.3 Phosphorylation of DCX at S332 modulates DCX-dependent neurite extension 
in mouse cortical neurons.  
Cultured primary cortical neurons at DIV2 were transfected with GFP, GFP-DCX-WT, or GFP-
DCX-S332A, and neurons were analyzed for neurite extension 48 h after transfection. Arrows 
indicate neurites. Scale bars, 100 μm. *, p < 0.05, **, p < 0.01, ***, p < 0.001. 
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RESULT-3: Phosphorylation of DCX at Ser332 
regulates neuronal migration 
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CHAPTER 4.   
RESULT-3: Phosphorylation of DCX at Ser332 regulates 
neuronal migration 
 
4.1 Scrape assay for neuronal migration  
I investigated whether phosphorylation of S332 of DCX affects neuronal migration. 
SH-SY5Y cells were transfected with GFP, GFP-DCX-WT, or GFP-DCX-S332A. After 
transfection, migration was assayed using the scrape migration method as described in 
Chapter 1. Briefly, the three scrapes were made at random by scratching with a sterile 
200 µl pipette tip. After scrapes, cells migrate into the scraped area and only trasfected 
cells were quantified in the scraped area (Fig. 1.5). 
 
4.2 Phosphorylation of DCX at Ser332 is required for DCX-enhanced 
neuronal migration 
SH-SY5Y cells expressing GFP-DCX-WT exhibited enhanced cell migration both 
at 24 and 48 h. This finding is consistent with the role of DCX in neuronal migration. 
However, these effects of DCX on neuronal migration were not observed in the cells 
expressing GFP-DCX-S332A (Fig. 4.1B).  
I also examined platelet-derived growth factor (PDGF)-induced neuronal migration 
(Huang et al., 2009) in the same assay, because PDGF enhances cell migration through 
JNK signaling (Amagasaki et al., 2006). After the scrape was made, 20 ng/ml PDGF 
was added into media, and the cells were incubated for 24 or 48 h. The results indicate 
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that PDGF-induced migration was significantly increased in cells expressing GFP-
DCX-WT, whereas expression of GFP-DCX-S332A had no effect on PDGF-induced 
cell migration (Fig. 4.1C). 
The results from the scrape migration assay indicate that phosphorylation of DCX at 
S332 is required for DCX-enhanced PDGF-dependent and PDGF-independent cell 
migration of neuronal cells.  
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Figure 4.1 Phosphorylation of DCX at S332 is required for DCX-enhanced neuronal 
migration.  
A. Time course of the experiments for scrape migration assay. B. Migration of SH-SY5Y cells 
expressing GFP-DCX-WT was enhanced over cells expressing GFP alone. SH-SY5Y cells 
expressing GFP-DCX-S332A demonstrated inhibited cell migration in the scrape migration 
assay. C. PDGF-induced migration of SH-SY5Y cells was also inhibited in cells expressing 
GFP-DCX-S332A. *, p < 0.05, **, p < 0.01, ***, p < 0.001. 
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RESULT-4: Phosphorylation of DCX by JNK 
lowers its binding to tubulin 
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CHAPTER 5.   
RESULT-4: Phosphorylation of DCX by JNK lowers its 
binding to tubulin 
 
5.1 Phosphorylation of DCX by JNK reduces its binding to tubulin 
To understand the mechanism of phosphorylation-dependent DCX function, I 
examined the interaction between DCX and tubulin because DCX binds to tubulin, and 
whether its affinity to tubulin is affected by its phosphorylation state as described for 
other MAPs such as tau protein (Avila et al., 1994).  
The interaction between DCX and tubulin was analyzed in cell lysates from cultured 
cortical neurons at DIV4. DCX was co-immunoprecipitated with tubulin by using an 
anti-β-tubulin antibody. Cortical neurons were cultured in the presence and absence of 
the JNK inhibitor for 4 h. Tubulin was first immunoprecipitated, and the resultant 
pellets were subjected to western blot analysis with an anti-DCX antibody.  
The presence of the JNK inhibitor increased amounts of DCX co-
immunoprecipitaed with tubulin (Fig. 5.1A).  
I next tested whether binding of DCX to microtubules is altered by phosphorylation 
at S332 by performing co-immunoprecipitation experiments. I transfected 293T cells 
with either GFP-DCX-WT or GFP-DCX-S332A. After 48 h, the cells were recovered, 
and the cell lysates were subjected to co-immunoprecipitation with anti-GFP antibody. 
The amount of bound tubulin was evaluated using western blot analysis with anti-β-
tubulin antibody. Larger amounts of tubulin from the transfected 293T cell lysates were 
co-immunoprecipitated with GFP-DCX-S332A than with GFP-DCX-WT (Fig. 5.1B).  
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When I incubated cultured cortical neurons with the Cdk inhibitor, roscovitine, no 
difference was detected in the binding between tubulin and DCX. These results indicate 
that phosphorylation of DCX by JNK lowers the amount DCX bound to tubulin, but 
Cdk5 has little effect on their binding (Fig. 5.1C). 
I then analyzed the DCX-tubulin interaction by using brain homogenates from 
Cdk5+/- and Cdk5-/- embryos at E18.5 (Fig. 5.1D). In Cdk5+/- mice, 
immunoprecipitated DCX was detected at high levels, whereas DCX levels were 
significantly reduced in Cdk5-/- mice. Because DCX was highly phosphorylated at 
S332 in Cdk5-/- brain (Fig. 2.4), these results further suggest that phosphorylation by 
JNK, not Cdk5, lowers the amount of DCX binding to tubulin in vivo.  
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Figure 5.1 Phosphorylation of DCX, including phosphorylation at S332, by JNK reduces 
its binding to tubulin.  
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A, C. Cultured primary cortical neurons at DIV4 were treated with or without the JNK inhibitor 
(A) or roscovitine, Cdk inhibitor (C). Cell lysates were subjected to immunoprecipitation with 
anti-β-tubulin antibody, and the amount of co-immunoprecipitated to DCX was determined 
using western blot analysis. The same membrane was re-blotted with the anti-β-tubulin antibody. 
B. Lysates of 293T cells expressing GFP-DCX-WT or GFP-DCX-S332A were co-
immunoprecipitated with anti-GFP antibody, and the amount of bound tubulin was detected 
using anti-β-tubulin antibody. The same membrane was re-blotted with anti-GFP-antibody. 
Elevated levels of DCX were found to bind to tubulin in the lysates of cortical neurons treated 
with JNK inhibitor (A) and in the lysates of 293T cells expressing GFP-DCX-S332A (B). 
Roscovitine treatment had no effect on the binding of DCX to tubulin (C). D. Brain 
homogenates from Cdk5+/- and Cdk5-/- embryos at E18.5 were subjected to co-
immunoprecipitation experiments. The interaction between DCX and tubulin was lower in the 
Cdk5-/- brain homogenates compared to that in the Cdk5+/- brain homogenates. n=4, *, p < 
0.05, **, p < 0.01.  
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5.2 Regulation of colocalization of microtubules and DCX 
phosphorylation 
I also tested colocalization of DCX and tubulin in COS cells expressing either GFP-
DCX-WT or GFP-DCX-S332A. After two days, transfected cells were fixed and 
subjected to immunocytochemistry for identifying colocalization between DCX and 
tubulin. 
The results revealed a higher correlation between DCX and tubulin in COS cells 
expressing GFP-DCX-S332A than in those expressing GFP-DCX-WT (Fig. 5.2). A 
similar degree of correlation was observed between DCX and tubulin when I treated 
COS cells expressing GFP-DCX-WT with JNK inhibitor (data not shown). These 
results suggest that binding of DCX to microtubules is altered by phosphorylation at 
JNK sites, including S332. 
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Figure 5.2 Higher colocalization of microtubules and DCX in COS cells expressing GFP-
DCX-S332A than in those expressing GFP-DCX-WT.  
COS cells were transfected with either GFP-DCX-WT or GFP-DCX-S332A. Localization of 
DCX associated with microtubules was examined by immunocytochemical study. Higher 
association was observed in COS cells expressing GFP-DCX-S332A than in those expressing 
GFP-DCX-WT. Scale bars, 20 μm. 
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CHAPTER 6.   
DISCUSSION 
 
DCX is a critical protein for neuronal migration in humans (Gleeson et al., 1998) 
and rodents (Bai et al., 2003; Koizumi et al., 2006). DCX functions as a MAP (Gleeson 
et al, 1999), and similar to that observed for other MAPs, phosphorylation regulates its 
affinity to microtubules (Avila et al., 1994). Therefore, DCX phosphorylation may 
modulate microtubule dynamics to regulate neuronal migration.  
A previous study has reported phosphorylation of DCX by JNK at Thr321, Thr331, 
and Ser334 in human DCX and the corresponding residues Thr326, Thr336, and Ser339 
in mouse DCX and modification of DCX function in neurite extension and neuronal 
migration (Gdalyahu et al., 2004). In the present study, I identified S332 of mouse DCX 
as another JNK phosphorylation site of DCX. I analyzed the physiological significance 
of S332 phosphorylation and found that phosphorylation of S332 is required for the 
function of DCX in neurite extension and neuronal migration. Furthermore, I 
demonstrated that JNK phosphorylation of DCX reduces its ability to bind to tubulin. I 
found that the interaction between DCX and tubulin was decreased in the Cdk5-/- 
embryonic brain. 
Analysis of Cdk5-/- mice, which exhibit neuronal migration defects (Ohshima et al., 
1996; Gilmore et al., 1998), indicated that DCX might be an important substrate of 
Cdk5 in neuronal migration. Experiments by Graham and colleagues demonstrated that 
DCX was phosphorylated by Cdk5 in vitro and identified multiple phosphorylation sites, 
including S332, by mass spectrometry (Graham et al., 2004). To date, Ser297 (S297) is 
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the only reported in vivo Cdk5 phosphorylation site of DCX, and phosphorylation levels 
of DCXS297 are decreased in the Cdk5-/- mouse brain (Tanaka et al, 2004; T.O., 
unpublished data). I generated phosphospecific anti-DCX antibodies to another 
phosphorylation sites to test phosphorylation levels of DCX at S332 in the Cdk5-/- 
embryonic brain. These results indicate that phosphorylation levels of S332 were 
unexpectedly elevated in the Cdk5-/- embryonic brain (Fig. 2.4), and this suggests that 
Cdk5 is not responsible for phosphorylation of S332. Because previous studies have 
demonstrated elevated activities of JNK and GSK3β in the Cdk5-/- embryonic brain and 
neurons that were treated with a Cdk inhibitor (Li et al., 2002; Morfini et al., 2004), I 
considered JNK and GSK3β as potential kinases involved in the phosphorylation of 
DCX at S332. Treatment of cells with JNK and GSK3β inhibitors revealed that JNK 
might be responsible for DCX phosphorylation at S332 because only treatment with the 
JNK inhibitor decreased phosphorylation of DCXS332 (Fig. 2.5B, 2.6). SP600125, 
which was used as a JNK inhibitor in this study, does not completely suppress JNK in a 
specific manner (Bai et al., 2003); however, anisomycin, which activates JNK, elevated 
S332 phosphorylation levels (Fig. 2.5C), and this finding supports the idea that JNK is 
the kinase that is responsible for the DCXS332 phosphorylation. Localization of 
pDCXS332 immunoreactivities in developing brain correlated with those of active JNK 
(Fig. 2.2A).  
Mice deficient in JNK1, JNK2, and JNK3 were generated, and these single-
knockout (KO) mice exhibit residual activity of JNK. Unfortunately, JNK1/JNK2 
double-KO mice exhibited an early embryonic lethal phenotype because of failure of 
neural tube closure (Kuan et al., 1999). Therefore, either of these JNK mutants may not 
be ideal for testing in vivo DCXS332 phosphorylation. Instead of the JNK mutants, I 
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used DLK-/- mouse brain to study phosphorylation of DCX at S332 in vivo, because 
DLK activates JNK, and decreased phosphorylation levels of other JNK-
phosphorylation sites of DCX have been reported in the brain of DLK-/- mice (Hirai et 
al., 2006). This finding that the level of phosphorylation of DCX S332 in DLK-/- mouse 
brain (Fig. 2.8) is low further supports the in vivo phopshorylation of DCX by JNK.  
Finally, I confirmed the direct phosphorylation of DCX by JNK by using an in vitro 
kinase assay with GST-DCX and a pDCXS332 antibody (Fig. 2.7). Specificity of this 
antibody was shown by the lack of immunoreaction with GST-DCX-S332A incubated 
with JNK (Fig. 2.7). A previous study has demonstrated that JNK phosphorylates DCX 
at three other sites, i.e., Thr326, Thr336, and Ser339 in mouse DCX (Gdalyahu et al., 
2004), but their results regarding DCX phosphorylation at S332 by JNK were 
inconclusive due to the lack of specific antibody for pDCXS332.  
I next investigated the physiological significance of phosphorylation of DCX at S332 
in neurite extension. I introduced GFP-DCX-WT into neuronal cells and found that 
DCX enhanced neurite extension; however, when I GFP-DCX-S332A was transfected, 
little effects on neurite extension were observed, indicating that S332 phosphorylation is 
required for DCX-induced neurite extension. Because expression of GFP-DCX-S332A 
increases neurite length (Fig. 3.3), phosphorylation of S332 of DCX is necessary but not 
sufficient for neurite extension. I also observed that JNK inhibitor treatment suppressed 
DCX-induced neurite extension (Fig. 3.2B). These results are consistent with a previous 
study, which indicated that JNK phosphorylation of DCX at the other three sites was 
necessary for neurite extension (Gdalyahu et al., 2004).  
I then studied the effect of phosphorylation of DCX at S332 on neuronal migration 
by using the scrape assay method. GFP only, GFP-DCX-WT, or GFP-DCX-S332A 
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were transfected into cells, and confluent SH-SY5Y cells were scraped 24 h later. GFP-
positive cells migrating into the scraped area were evaluated after 24 or 48 h. Migration 
was enhanced in SH-SY5Y cells expressing GFP-DCX-WT but not in those expressing 
GFP-DCX-S332A (Fig. 4.1), indicating that DCX positively regulates migration of SH-
SY5Y cells and that S332 phosphorylation is important for DCX-induced migration. 
DLK activates JNK, and DLK-/- mice exhibit neuronal migration defects in the 
developing cerebral cortex (Hirai et al., 2006). Because hypophosphorylation of DCX at 
JNK-phosphorylation sites was detected in the DLK-/- mouse brain (Hirai et al., 2006 
and present study), DCX possibly contributes to the migration-defect phenotype of 
DLK-/- mice, and this finding is consistent with the finding of the scrape assay 
experiment in this study. Consistent with the findings of previous studies, these results 
indicate that phosphorylation of DCX at S332 by JNK is critical for neurite extension 
and neuronal migration. 
Microtubule dynamics is a necessary attribute of the cytoskeleton in the migration 
of neurons (Gordon-Weeks, 2004). DCX is one of the proteins that confer the unique 
microtubule properties to neurons, and neurons in early development have high DCX 
expression levels (Gleeson et al., 1999). Phosphorylation of DCX may be a regulatory 
mechanism that modulates this dynamic regulation in migrating neurons. Previous 
reports have shown that in vitro phosphorylation of DCX by Cdk5 lowers its affinity to 
microtubules through an effect on microtubule dynamics (Tanaka et al., 2004). In the 
present study, I demonstrated that phosphorylation of DCX by JNK also weakened the 
interaction between DCX and tubulin. In addition, the results of this study showed that 
S332 phosphorylation is important for the binding of DCX to tubulin (Fig. 5.1B, 5.2). 
Interestingly, the analysis of Cdk5-/- embryonic brain homogenates showed elevated 
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DCX phosphorylation at S332 (Fig. 2.4B) and reduced interaction between DCX and 
tubulin (Fig. 5.1D). These results indicate that phosphorylation of DCX by JNK is more 
critical than phosphorylation by Cdk5 in the mouse brain, and this may be due to the 
greater number of in vivo JNK phosphorylation sites; it has been shown that Cdk5 
phosphorylates DCX at S297, while JNK phosphorylates DCX at four sites in the 
mouse brain.  
JNK activity in the IZ and IZ-cortical plate (CP) in the cerebral cortex was high at 
E14-16 (Hirai et al., 2002; Kawauchi et al., 2003; Fig. 2.2A) as well as in the 
premigratory zone in developing cerebellar cortex (Fig. 2.2B), and high levels of DCX 
phosphorylation at JNK sites were observed in these areas (Gdalyahu et al., 2004 and 
present study). On the basis of the expression patterns of its activating subunits p35 and 
p39, Cdk5 activity was shown to be high in the IZ-CP and CP (Ohshima et al., 2002). 
The phosphorylation state of DCX by several kinases, including JNK and Cdk5, will 
dynamically change in different migratory steps in radial migration in the cerebral and 
cerebellar cortices. Cortical neurons change their morphology from multipolar to 
bipolar in radial migration (Tabata and Nakajima 2003; Noctor et al., 2004), and both 
treatment with DCX RNAi (Bai et al., 2003) and loss of Cdk5 impair this transition 
(Ohshima et al., 2007). Delayed migration of cortical neurons in the IZ-CP was 
observed in DLK-/- mice (Hirai et al., 2006). These results indicate a critical function of 
DCX and DCX phosphorylation by JNK and Cdk5 in migratory behavior in the IZ-CP.  
I observed elevated levels of phospho-DCX in the Cdk5-/- brain (Fig. 2.4), and 
roscovitine treatment did not alter DCXS332 phosphorylation levels in cortical neurons 
(Fig. 2.5A). These data support the conclusion that Cdk5 does not phosphorylate S332 
of DCX in vivo and also indicate that the increase in pS332 levels are not the result of 
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release of enzymatic inhibition of Cdk5 to JNK. Because high levels of active JNK have 
been observed in the premigratory and migrating neurons in the developing cerebral and 
cerebellar cortices (Hirai et al., 2002; Kawauchi et al., 2003; Fig. 2.2), immature 
neurons may exhibit high JNK activity. DCX is also highly expressed in immature-stage 
neurons, and levels of DCX are elevated in the Cdk5-/- embryonic brain (Fig. 2.4A); 
this finding suggests a delay in neuronal maturation in the Cdk5-/- embryonic brain. 
The results of the immunohistochemical study of the embryonic brain show that JNK 
and Cdk5 activities are dependent on neuronal maturation, as discussed above. 
Therefore, the correlation of kinase activity with neuronal maturation may be important 
for proper neuronal migration. Further detailed comparative study of JNK and Cdk5 
kinase activities and migratory behavior of neurons as well as analysis of neuronal 
migration using kinase inhibitors, as demonstrated in a recent study by Nishimura and 
colleagues (Nishimura et al., 2010), will provide new insights into the mechanistic 
regulation of these kinases in neuronal migration.  
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CHAPTER 7.   
CONCLUSION 
 
In this study, I examine the phosphorylation-mediated functional regulation of DCX. 
DCX is a critical molecule in neuronal migration because lack of DCX causes human 
disorder called “lissencephaly”. DCX function as microtubule-associated protein (MAP). 
Similar to other MAPs, binding of DCX to microtubule is regulated by phosphorylation 
status of its C-terminal Ser/Thr-rich domain. Previous studies demonstrated that Cdk5 
and JNK are involved in the phosphorylation of C-terminal domain of DCX.  
I showed here that DCX is phosphorylated at S332 by JNK, not by Cdk5 in vivo. 
My experimental results suggest that the phosphorylation of DCX at S332 is required 
for neurite extension and neuronal migration.  
My results indicate that JNK-mediated phosphorylation of DCX is critical in its binding 
to microtubules in mouse brain. Along with previous studies by others, my experimental 
data suggest that JNK pathway is linked to regulate cerebral cortex development. 
Positioning of DCX in the JNK pathway opens up the possibilities of understanding 
how neuronal migration is regulated and what is the role of the JNK in cortical layering.  
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FUTURE PROSPECT 
 
This research has attempted to identify functional significance of the 
phosphorylation of DCX by JNK. Phosphorylation of DCX by JNK was considered on 
the assembly dynamics of microtubules. However, how phosphorylated DCX by JNK 
regulates neurite extension and neuronal migration through its binding to microtubules 
is not clearly understood yet. In the future, I hope that this research not only enhances 
understanding of the regulatory mechanism of JNK-mediated phosphorylation of DCX 
function, but also contributes to the understanding of the molecular mechanisms that 
regulate the brain formation. 
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